European Respiratory Society

The latest from ERS on SARS-CoV-2 and COVID-19
ERS has created a page bringing together all its SARS-CoV-2 and COVID-19 resources for professionals, including webinars, patient resources and publications
COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD
The COVID-19 pandemic has changed healthcare provision and access. This study shows a 38% increase in the number of community treated AECOPD in 2020 compared with 2019, alongside increased anxiety and inhaler adherence with reduced physical activity.
Collaborative tuberculosis/HIV activities in the European Region
TB and HIV care are well integrated in policies of especially high TB and high HIV burden countries. Continuous monitoring of HIV and TB service integration enables identification of where further improvements are needed.
Validation of the Swedevox registry of continuous positive airway pressure, long-term mechanical ventilator and long-term oxygen therapy
The National Swedish Registry for Respiratory Failure (Swedevox) of CPAP, long-term mechanical ventilator and long-term oxygen has high validity compared with medical records, and is suitable for follow-up of medical care and for clinical research
Higher interleukin-6 levels and changes in transforming growth factor-β are associated with lung impairment in pulmonary tuberculosis
Higher levels of IL-6 and slow-to-resolve TGF-β are associated with lung impairment in treated tuberculosis. These results have important implications for clinical trials of immunomodulatory therapies to prevent tuberculosis-associated lung disease.

Latest Articles

Extended lifespan of bronchial epithelial cells maintains normal cellular phenotype and transcriptome integrity
Jonathan O'Loughlin, Robert J. Hall, Sangita Bhaker, Michael A. Portelli, Amanda Henry, Vincent Pang, David O. Bates, Tyson V. Sharp, Ian Sayers

ERJ Open Research Jan 2021, 7 (1) 00254-2020; DOI: 10.1183/23120541.00254-2020
Avatar acceptability: views from the Australian Cystic Fibrosis community on the use of personalised organoid technology to guide treatment decisions
Laura K. Fawcett, Claire E. Wakefield, Sheila Sivam, Peter G. Middleton, Peter Wark, John Widger, Adam Jaffe, Shafagh A. Waters

ERJ Open Research Jan 2021, 7 (1) 00448-2020; DOI: 10.1183/23120541.00448-2020
Systematic review of diagnostic methods for acute respiratory distress syndrome
Laura A. Hagens, Nanon F.L. Heijnen, Marry R. Smit, Marcus J. Schultz, Dennis C.J.J. Bergmans, Ronny M. Schnabel, Lieuwe D.J. Bos

ERJ Open Research Jan 2021, 7 (1) 00504-2020; DOI: 10.1183/23120541.00504-2020
The six million dollar man
Mathilde Volpato, Stefan Nowak, Jean Luc Bourrain, Pascal Demoly, Engi Ahmed, Arnaud Bourdin, Jeremy Charriot

ERJ Open Research Jan 2021, 7 (1) 00341-2020; DOI: 10.1183/23120541.00341-2020
Validation of the Swedevox registry of continuous positive airway pressure, long-term mechanical ventilator and long-term oxygen therapy
Magnus Ekström, Dirk Albrecht, Susanne Andersson, Ludger Grote, Birgitta Kärrsten Rundström, Andreas Palm, Jenny Theorell-Haglöw, Josefin Wahlberg, Bengt Midgren

ERJ Open Research Jan 2021, 7 (1) 00340-2020; DOI: 10.1183/23120541.00340-2020
COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD
Hamish McAuley, Kate Hadley, Omer Elneima, Christopher E. Brightling, Rachael A. Evans, Michael C. Steiner, Neil J. Greening

ERJ Open Research Jan 2021, 7 (1) 00718-2020; DOI: 10.1183/23120541.00718-2020

About ERJ Open Research

ERJ Open Research is a new fully open access original research journal, published online by the European Respiratory Society. The journal aims to publish high-quality work in all fields of respiratory science and medicine, covering basic science, clinical translational science and clinical medicine.

Tweets by @ERSpublications

Main menu

User menu

Search

Latest Articles

About ERJ Open Research

Contact us